Implantable electrical bone stimulation for arthrodeses of the foot and ankle in high-risk patients: a multicenter study.
This study assessed arthrodesis procedures performed in the foot and ankle of high-risk patients following implantation of an internal electrical bone stimulator. Criteria defining patients as "high risk" included diabetes, obesity, habitual tobacco and/or alcohol use, immunosuppressive therapy, and previous history of nonunion. Standard arthrodesis protocol of bone graft and internal fixation was supplemented with the implantable electrical bone stimulator. A retrospective, multicenter review was conducted of 26 patients (28 cases) who underwent 28 forefoot and hindfoot arthrodeses from 1998 to 2002. Complete fusion was defined as bony trabeculation across the joint, lack of motion across the joint, maintenance of hardware/fixation, and absence of radiographic signs of nonunion or pseudoarthrosis. Radiographic consolidation was achieved in 24 of the 28 cases at an average 10.3+/-4.0 weeks. Followup averaged 27.2 months. Complications included 2 patients who sustained breakage of the cables to the bone stimulator. Five patients underwent additional surgery. Four of the 5 patients had additional surgery in order to achieve arthrodesis. All 4 went on to subsequent arthrodesis. This study demonstrates how arthrodesis of the foot and ankle may be enhanced by the use of implantable electrical bone stimulation.
Saxena
Amol
A
Department of Sports Medicine, Palo Alto Medical Foundation, Palo Alto, CA 94301, USA. heysax@aol.com
DiDomenico
Lawrence A
LA
Widtfeldt
Arthur
A
Adams
Todd
T
Kim
Will
W
D000328:Adult; D000368:Aged; D000428:Alcohol Drinking / Q000009:adverse effects; D000843:Ankle Joint / Q000601:surgery*; D001174:Arthrodesis; D016025:Bone Transplantation; D048909:Diabetes Complications; D004599:Electric Stimulation Therapy; D005260:Female; D005500:Follow-Up Studies; D033023:Foot Joints / Q000601:surgery*; D005593:Fracture Fixation, Internal; D017102:Fracture Healing; D005599:Fractures, Ununited / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010012:Osteogenesis; D012189:Retrospective Studies; D012907:Smoking / Q000009:adverse effects